Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical diabetology and metabolism.ORCID iD: 0000-0003-1270-2221
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical diabetology and metabolism.ORCID iD: 0000-0002-0964-6700
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical diabetology and metabolism.ORCID iD: 0009-0006-4330-5674
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical diabetology and metabolism.ORCID iD: 0000-0002-7920-8909
Show others and affiliations
2025 (English)In: Endocrine, ISSN 1355-008X, E-ISSN 1559-0100, Vol. 90, p. 1459-1471Article in journal (Refereed) Published
Abstract [en]

Purpose: Obesity is associated with neuroendocrine and metabolic dysregulation, yet the underlying mechanisms remain incompletely understood. This study aimed to investigate how pituitary hormonal axes and peripheral hormones respond to a cafeteria diet or a calorie-restricted diet in rats.

Methods: Ten-week-old male Wistar rats (n = 36) were randomized (1:1:1) to one of three diets for 12 weeks: an ad libitum standard rat chow diet (control group); an ad libitum cafeteria diet, containing cheese doodles, chocolate balls and salted peanuts, in addition to standard chow (diet-induced obesity group, DIO); or calorie-restriction (aiming at 85% body weight of controls; restricted group). We assessed endocrine gland weights, plasma levels of pituitary hormones and related peripheral signals, and explored their associations with metabolic and behavioral outcomes.

Results: While the DIO group exhibited increased body weight, insulin resistance, and altered metabolic markers, only modest changes in pituitary hormones were observed, with a reduction in luteinizing hormone (p < 0.05). Correlation analysis showed that when combining the control and DIO groups, prolactin inversely correlated with exploratory-activity (rho =-0.458, p < 0.05) from the behavioral test. In contrast, the restricted group showed more pronounced hormonal changes, including reduced levels of adrenocorticotropic hormone (p < 0.01), prolactin, and thyroid-stimulating hormone (both p < 0.05) as well as insulin-like growth factor-1 (p < 0.01). Multivariate data analysis showed a clear separation of the DIO group from the other groups, mainly driven by metabolic variables.

Conclusion: Despite notable metabolic perturbations in the DIO group, the absence of endocrine changes suggests a partly different phenotype than what is typically observed in humans with obesity.

Place, publisher, year, edition, pages
Springer Nature, 2025. Vol. 90, p. 1459-1471
Keywords [en]
Calorie restriction, Diet-induced obesity, MCSF, Metabolism, Obesity, Pituitary hormones
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-582609DOI: 10.1007/s12020-025-04448-9ISI: 001595127400001PubMedID: 41091300Scopus ID: 2-s2.0-105018888764OAI: oai:DiVA.org:uu-582609DiVA, id: diva2:2047293
Part of project
Stress, reward and homeostasis. Role of the brain´s neural networks and their interplay with peripheral tissues in type 2 diabetes development, Swedish Research Council
Funder
Swedish Foundation for Strategic Research, CMP22-0014Swedish Research Council, 2024-03344Uppsala UniversityEU, Horizon Europe, 101080329Diabetesfonden, DIA2021–661Diabetesfonden, DIA2024-935Novo Nordisk Foundation, NNF20OC0063864Novo Nordisk Foundation, NNF23OC0084483Ernfors FoundationAvailable from: 2026-03-19 Created: 2026-03-19 Last updated: 2026-04-10Bibliographically approved
In thesis
1. Brain-periphery crosstalk in obesity and type 2 diabetes development: Glucose regulation, hormones, neurotransmitters, and behaviour
Open this publication in new window or tab >>Brain-periphery crosstalk in obesity and type 2 diabetes development: Glucose regulation, hormones, neurotransmitters, and behaviour
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Obesity and its metabolic consequences, such as insulin resistance and type 2 diabetes (T2D), have become a global health challenge. While peripheral regulation of glucose and lipid metabolism is well characterized, central brain regulation is also a key component in the control of energy and glucose homeostasis. However, knowledge remains limited regarding how these systems are integrated and how they affect or are affected by obesity and T2D. The overall aim of this thesis was to further elucidate the brain’s contribution to the development of obesity and T2D and to identify mechanisms that may be relevant for future interventions.

In Paper I, the short-term metabolic effects of obesity surgery (OS) and low-calorie diet (LCD) were compared in individuals with obesity using oral glucose tolerance testing, hyperinsulinaemic-euglycaemic clamp, and whole-body integrated 18F-FDG-PET/MRI. Although OS and LCD induced similar reductions in body weight and adiposity, only OS produced rapid improvements in fasting glucose homeostasis and insulin resistance, together with altered tissue-specific glucose uptake, indicating early metabolic effects beyond weight loss alone.

In Papers II–IV, the same rat cohort was used to examine the effects of cafeteria diet and caloric restriction over 12 weeks. In Paper II, the cafeteria diet induced a clear adverse metabolic phenotype with higher adiposity, insulin resistance, and prediabetes, whereas caloric restriction produced a somewhat healthier phenotype than controls. Despite these metabolic differences, behavioural profiling revealed no significant group differences. In Paper III, endocrine analyses showed that caloric restriction induced more pronounced hormonal alterations than the cafeteria diet, which caused only modest pituitary changes. Finally, in Paper IV, matrix-assisted laser desorption/ionization mass spectrometry imaging demonstrated widespread, region-specific changes in brain biogenic amine signalling after both dietary interventions, with overlapping neurochemical patterns despite opposite metabolic states.

In conclusion, this thesis demonstrates that obesity, caloric restriction, and metabolic interventions are associated with coordinated adaptations across peripheral metabolic regulation, endocrine regulation, and central neuro-chemical systems. Moreover, it shows an important role of brain-periphery crosstalk in metabolic disease, and highlights central pathways that may serve as potential targets for future clinical interventions, aiming to improve the prevention and treatment of obesity and T2D.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2026. p. 69
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2268
Keywords
Obesity, type 2 diabetes, brain-periphery crosstalk, glucose homeostasis, neuroendocrine regulation, biogenic amines, behaviour, diet-induced obesity, cafeteria diet, caloric restriction, mass spectrometry imaging
National Category
Endocrinology and Diabetes
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-584213 (URN)978-91-513-2822-5 (ISBN)
Public defence
2026-06-03, Fåhraeussalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20, Uppsala, 09:00 (English)
Opponent
Supervisors
Funder
Novo Nordisk Foundation, NNF23OC0084483, NNF25OC0101843EXODIAB - Excellence of Diabetes Research in SwedenErnfors FoundationP.O. Zetterling FoundationAgnes and Mac Rudberg FoundationDiabetesfonden, DIA2021–661, DIA2024-935EU, Horizon Europe, RIA project PAS GRAS 101080329Swedish Foundation for Strategic Research, CMP22-0014Swedish Research Council, 2024-03344Science for Life Laboratory, SciLifeLab
Note

Other funders that were not included in the list:

-Uppsala Diabetes Center (UDC)

-Uppsala University Hospital ALF grants

Available from: 2026-05-07 Created: 2026-04-10 Last updated: 2026-05-07

Open Access in DiVA

fulltext(1770 kB)18 downloads
File information
File name FULLTEXT01.pdfFile size 1770 kBChecksum SHA-512
18247ae583fcb573ece5062cdd8f4d65ee30f925ae10c231860380500175791c9aec3b94c951a94e38a2d7ccf1de50bec9b94f981660b670f8fded99ef7ee21b
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Kagios, ChristakisHetty, SusanneHukema, Fleur W.Fanni, GiovanniRoman, ErikaEriksson, Jan

Search in DiVA

By author/editor
Kagios, ChristakisHetty, SusanneHukema, Fleur W.Fanni, GiovanniRoman, ErikaEriksson, Jan
By organisation
Clinical diabetology and metabolismDepartment of Pharmaceutical Biosciences
In the same journal
Endocrine
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 2640 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf